Achalasia and acromegaly: Co-incidence of these diseases or a new syndrome?
- PMID: 34282806
- DOI: 10.5507/bp.2021.040
Achalasia and acromegaly: Co-incidence of these diseases or a new syndrome?
Abstract
Background: Acromegaly is a disorder associated with hypersecretion of growth hormone, most usually caused by a pituitary adenoma. Dysmotility of the gastrointestinal tract has been reported in acromegalic patients. Achalasia is a disorder characterized by aperistalsis of the oesophagus with incomplete lower oesophageal sphincter relaxation and whose aetiology remains unknown. Mutations in some genes have previously been associated with the development of acromegaly or achalasia. The study aims were to analyse mutations in selected genes in a woman having both of these diseases, to identify their aetiological factors, and to suggest explanations for the co-incidence of acromegaly and achalasia.
Methods and results: A female patient with acromegaly, achalasia, and a multinodular thyroid gland with hyperplastic colloid nodules underwent successful treatment of achalasia via laparoscopic Heller myotomy, a thyroidectomy was performed, and the pituitary macroadenoma was surgically excised via transnasal endoscopic extirpation. Germline DNA from the leukocytes was analysed by sequencing methods for a panel of genes. No pathogenic mutation in AAAS, AIP, MEN1, CDKN1B, PRKAR1A, SDHB, GPR101, and GNAS genes was found in germline DNA. The somatic mutation c.601C>T/p.R201C in the GNAS gene was identified in DNA extracted from a tissue sample of the pituitary macroadenoma.
Conclusions: We here describe the first case report to our knowledge of a patient with both acromegaly and achalasia. Association of acromegaly and soft muscle tissue hypertrophy may contribute to achalasia's development. If one of these diagnoses is determined, the other also should be considered along with increased risk of oesophageal and colorectal malignancy.
Keywords: AAAS; GNAS; GPR101; achalasia; acromegaly; autoimmune syndrome; gene; mutation; pituitary tumour.
Conflict of interest statement
The authors report no conflicts of interest in this work.
Similar articles
-
Somatic GNAS mutation causes widespread and diffuse pituitary disease in acromegalic patients with McCune-Albright syndrome.J Clin Endocrinol Metab. 2012 Jul;97(7):2404-13. doi: 10.1210/jc.2012-1274. Epub 2012 May 7. J Clin Endocrinol Metab. 2012. PMID: 22564667 Free PMC article.
-
Very low frequency of germline GPR101 genetic variation and no biallelic defects with AIP in a large cohort of patients with sporadic pituitary adenomas.Eur J Endocrinol. 2016 Apr;174(4):523-30. doi: 10.1530/EJE-15-1044. Epub 2016 Jan 20. Eur J Endocrinol. 2016. PMID: 26792934
-
Genetics of Acromegaly and Gigantism.J Clin Med. 2021 Mar 29;10(7):1377. doi: 10.3390/jcm10071377. J Clin Med. 2021. PMID: 33805450 Free PMC article. Review.
-
Somatotroph pituitary adenoma with acromegaly and autosomal dominant polycystic kidney disease: SSTR5 polymorphism and PKD1 mutation.Pituitary. 2012 Sep;15(3):342-9. doi: 10.1007/s11102-011-0325-0. Pituitary. 2012. PMID: 21744088 Free PMC article.
-
Pituitary tumours: molecular and genetic aspects.J Endocrinol. 2023 May 12;257(3):e220291. doi: 10.1530/JOE-22-0291. Print 2023 Jun 1. J Endocrinol. 2023. PMID: 36951812 Review.
References
-
- Colao A, Ferone D, Marzullo P, Lombardi G. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 2004;25(1):102-52. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous